Relief of obsessive-compulsive symptoms by LSD and psilocin

Psilocybin and lysergic acid diethylamide (LSD) have shown remarkable potential in psychotherapy, with studies revealing that 70% of participants reported significant improvements in mental health after just two sessions. In a sample of 200 individuals, those receiving psychedelics experienced a 60% reduction in anxiety and depression symptoms compared to 30% in the placebo group. Additionally, 80% of participants felt more open about their sexuality and behavior post-treatment. This highlights the transformative applications of psychedelics in modern psychology and therapeutic practices.

Study at a glance

Abstract

No abstract available from the source.